FGFR3 and cancer: However, since high levels of FGFR3 expression, associated with a cancer-related mutation, were described in SK-N-MC cells [18, 19], we analyzed tyrosine phosphorylation of this receptor by western blotting which confirmed the roneparstat-induced inhibition (Figure 2B).